BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giuliano V, Bassotti G, Mourvaki E, Castellani D, Filippucci E, Sabatino G, Gizzi S, Palmerini F, Galli F, Morelli O. Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res. 2010;126:12-17. [PMID: 20051286 DOI: 10.1016/j.thromres.2009.11.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Adkins C, Rezaie A. Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs? Dig Dis Sci 2018;63:271-2. [DOI: 10.1007/s10620-017-4904-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Huang W, Zhang W. Pharmacomicrobiomics. In: Cai W, Liu Z, Miao L, Xiang X, editors. Pharmacogenomics in Precision Medicine. Singapore: Springer; 2020. pp. 181-99. [DOI: 10.1007/978-981-15-3895-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Purnak T, Yuksel O. Overview of venous thrombosis in inflammatory bowel disease. Inflamm Bowel Dis 2015;21:1195-203. [PMID: 25581828 DOI: 10.1097/MIB.0000000000000274] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
4 Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. Gastroenterology 2020;159:1526-32. [PMID: 32679220 DOI: 10.1053/j.gastro.2020.06.090] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
5 Kastl AJ Jr, Terry NA, Wu GD, Albenberg LG. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cell Mol Gastroenterol Hepatol 2020;9:33-45. [PMID: 31344510 DOI: 10.1016/j.jcmgh.2019.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 18.3] [Reference Citation Analysis]
6 Steffen KJ, Wonderlich JA, Erickson AL, Strawsell H, Mitchell JE, Crosby RD. Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery. Pharmacotherapy 2015;35:876-80. [PMID: 26406775 DOI: 10.1002/phar.1632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
7 Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol 2017; 23(7): 1241-1249 [PMID: 28275304 DOI: 10.3748/wjg.v23.i7.1241] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ciffolilli S, Wallert M, Bartolini D, Krauth V, Werz O, Piroddi M, Sebastiani B, Torquato P, Lorkowski S, Birringer M, Galli F. Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite α-(13'-hydroxy)-6-hydroxychroman. Free Radical Biology and Medicine 2015;89:952-62. [DOI: 10.1016/j.freeradbiomed.2015.08.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
9 Oliveira RB, Martinelli ALC, Troncon LEA, Elias J Jr. Small intestinal bacterial overgrowth (SIBO) and vitamin K-responsive coagulopathy: a previously unrecorded association. BMJ Case Rep 2018;2018:bcr-2017-223531. [PMID: 29880619 DOI: 10.1136/bcr-2017-223531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]